Investigating fresh gas flow effects on nausea and vomiting after septorhinoplasty
Effects of Different Fresh Gas Flow Applications on Postoperative Nausea and Vomiting in Septorhinoplasty Surgeries
This study is testing whether different levels of fresh gas flow during anesthesia can reduce nausea and vomiting in patients after nose surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Adiyaman University Research Hospital Academic / other |
| Locations | 1 site (Adıyaman, Merkez) |
| Trial ID | NCT06952946 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate how different fresh gas flow rates during general anesthesia impact the occurrence of postoperative nausea and vomiting in patients undergoing septorhinoplasty. Participants will be divided into three groups based on the fresh gas flow applied: low flow (0.5 lt/min), medium flow (2 lt/min), and high flow (4 lt/min). The study will monitor and compare the incidence of nausea and vomiting, as well as the use of antiemetics and opioids, across these groups. Data will be collected at various postoperative intervals to assess the effectiveness of each flow rate.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-65 who are classified as ASA I-II and agree to participate.
Not a fit: Patients with psychiatric disorders, cognitive dysfunction, or those classified as ASA III-IV will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management of postoperative nausea and vomiting, enhancing recovery for patients undergoing septorhinoplasty.
How similar studies have performed: While the specific approach of varying fresh gas flow rates is less commonly studied, similar studies have shown that anesthesia techniques can significantly impact postoperative outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who agreed to participate in the study * 18-65 years of age * ASA I-II risk group patients Exclusion Criteria: * Patient does not accept the study * Presence of psychiatric disorder and patient's inability to cooperate * Cognitive dysfunction * Hearing problems * History of alcohol or drug addiction * Presence of a serious pre-existing medical condition that limits objective assessment * Complications developed during surgery * Presence of any life-threatening condition after surgery * Patient's classification is ASA III-IV
Where this trial is running
Adıyaman, Merkez
- Adıyaman Training and Research Hospital — Adıyaman, Merkez, Turkey (Recruiting)
Study contacts
- Study coordinator: Ufuk Karbaş
- Email: ufukkarbas@hotmail.com
- Phone: +905432652489
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.